The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Michael G. Aman

The Nisonger Center

The Ohio State University

Columbus

Ohio 43210

USA

[email]@osu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • The Nisonger Center, The Ohio State University, Columbus, Ohio 43210, USA. 2002 - 2010
  • Department of Psychology, Ohio State University, 225 Psychology Building, 1835 Neil Avenue, USA. 2008
  • The Nisonger Center for Mental Retardation and Developmental Disabilities, Ohio State University, Columbus 43210-1296, USA. 2000

References

  1. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. Aman, M.G., Kasper, W., Manos, G., Mathew, S., Marcus, R., Owen, R., Mankoski, R. J. Child. Adolesc. Psychopharmacol (2010) [Pubmed]
  2. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. Aman, M.G., McDougle, C.J., Scahill, L., Handen, B., Arnold, L.E., Johnson, C., Stigler, K.A., Bearss, K., Butter, E., Swiezy, N.B., Sukhodolsky, D.D., Ramadan, Y., Pozdol, S.L., Nikolov, R., Lecavalier, L., Kohn, A.E., Koenig, K., Hollway, J.A., Korzekwa, P., Gavaletz, A., Mulick, J.A., Hall, K.L., Dziura, J., Ritz, L., Trollinger, S., Yu, S., Vitiello, B., Wagner, A. J. Am. Acad. Child. Adolesc. Psychiatry (2009) [Pubmed]
  3. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Aman, M.G., Farmer, C.A., Hollway, J., Arnold, L.E. Child. Adolesc. Psychiatr. Clin. N. Am (2008) [Pubmed]
  4. The Nisonger Child Behavior Rating Form: typical IQ version. Aman, M., Leone, S., Lecavalier, L., Park, L., Buican, B., Coury, D. Int. Clin. Psychopharmacol (2008) [Pubmed]
  5. Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders. Aman, M.G., Vinks, A.A., Remmerie, B., Mannaert, E., Ramadan, Y., Masty, J., Lindsay, R.L., Malone, K. Clin. Ther (2007) [Pubmed]
  6. Project MED: effects of a Medication EDucation booklet series for individuals with intellectual disabilities. Aman, M.G., Benson, B.A., Farmer, C.A., Hall, K.L., Malone, K.M. Intellectual. Developmental. Disabilities (2007) [Pubmed]
  7. Medication patterns in patients with autism: temporal, regional, and demographic influences. Aman, M.G., Lam, K.S., Van Bourgondien, M.E. J. Child. Adolesc. Psychopharmacol (2005) [Pubmed]
  8. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ. Aman, M., Buitelaar, J., Smedt, G.D., Wapenaar, R., Binder, C. J. Child. Adolesc. Psychopharmacol (2005) [Pubmed]
  9. Acute and long-term safety and tolerability of risperidone in children with autism. Aman, M.G., Arnold, L.E., McDougle, C.J., Vitiello, B., Scahill, L., Davies, M., McCracken, J.T., Tierney, E., Nash, P.L., Posey, D.J., Chuang, S., Martin, A., Shah, B., Gonzalez, N.M., Swiezy, N.B., Ritz, L., Koenig, K., McGough, J., Ghuman, J.K., Lindsay, R.L. J. Child. Adolesc. Psychopharmacol (2005) [Pubmed]
  10. Treatment planning for patients with autism spectrum disorders. Aman, M.G. J. Clin. Psychiatry (2005) [Pubmed]
  11. Outcome measures for clinical drug trials in autism. Aman, M.G., Novotny, S., Samango-Sprouse, C., Lecavalier, L., Leonard, E., Gadow, K.D., King, B.H., Pearson, D.A., Gernsbacher, M.A., Chez, M. CNS. Spectr (2004) [Pubmed]
  12. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. Aman, M.G., Gharabawi, G.M. J. Clin. Psychiatry (2004) [Pubmed]
  13. Four-year follow-up of children with low intelligence and ADHD: a replication. Aman, M.G., Armstrong, S., Buican, B., Sillick, T. Res. Dev. Disabil (2002) [Pubmed]
  14. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Aman, M.G., De Smedt, G., Derivan, A., Lyons, B., Findling, R.L. Am. J. Psychiatry (2002) [Pubmed]
  15. Pharmacotherapy of disorders in mental retardation. Aman, M.G., Collier-Crespin, A., Lindsay, R.L. Eur. Child. Adolesc. Psychiatry (2000) [Pubmed]
 
WikiGenes - Universities